The Su2ura® GI System is now at the center of a new clinical trial dedicated to addressing challenging mucosal, submucosal, and perforation defects during endoscopic procedures. This innovative device aims to refine suturing for defects occurring after Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Anchora Medical leads this research effort to substantiate the system’s safety and performance.
What changed?
The Su2ura® GI System is being evaluated in a trial facilitated by Anchora Medical to advance closure techniques for complications arising from EMR and ESD. Eligible participants will undergo pre-defined diagnostic tests, including health-related quality-of-life (HR-QoL) assessments and hematology tests. This trial underscores the system’s potential to make a significant clinical impact.
What are the trial details?
The trial, now recruiting participants, will investigate the Su2ura® GI System’s ability to provide effective full-thickness suturing in cases involving mucosal, submucosal, or perforated defects. A comprehensive diagnostics approach will guide the evaluation process:
- Physical examinations
- Vital signs monitoring
- Blood analyses (hematology, biochemistry)
- Pregnancy testing (urine-based)
- Gastroscopy
The research also includes the Visual Analogue Scale (VAS) for patient-reported outcomes and an HR-QoL evaluation, aligning with a patient-focused approach.
How does the Su2ura® GI System work?
The Su2ura® GI System offers a methodical solution for endoluminal suturing:
- Intended Purpose: Closure of mucosal, submucosal, and perforation defects that commonly challenge traditional repair methods.
- Performance: Precision-based suturing functionality tailored to the unique needs of endoscopic environments.
- Safety: Anchora Medical confirms adherence to regulatory standards as part of the trial to evaluate safety in clinical application.
Anchora Medical’s methodologies aim to bridge technological advancements with immediate clinical needs, offering options for complex defect repairs.
Frequently Asked Questions
- Who qualifies for this trial? Individuals undergoing EMR or ESD procedures with identifiable closure needs may qualify based on inclusion and exclusion criteria.
- What is the primary goal of the trial? To evaluate the Su2ura® GI System’s effectiveness in securely closing full-thickness defects.
- Are there risks involved? Like all clinical investigations, patient safety is rigorously monitored, with adverse events managed according to predefined protocols.
Conclusion
This trial marks a significant step in leveraging innovative devices for more effective outcomes in endoluminal suturing. Anchora Medical’s focus on patient-centered diagnostics and advanced technology could shift longstanding challenges in clinical practice. Industry and regulatory professionals should closely track updates from this pivotal research effort.
Disclaimer
This article is intended for professionals in clinical, regulatory, or quality domains. It does not constitute legal or medical advice.
Reference
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07315893?term=medical+device